Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPTX
1776
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $18.7M | ﹤0.01% |
299,739
+192,681
| +180% | +$9.17M |
|
|
VBTX
1777
DELISTED
Veritex Holdings
VBTX
| $18.7M | ﹤0.01% |
640,635
-32,311
| -5% | -$830K |
|
1778
Columbus McKinnon
CMCO
$550M
| $18.7M | ﹤0.01% |
466,020
-8,385
| -2% | -$324K |
|
1779
Appian
APPN
$2.65B
| $18.6M | ﹤0.01% |
488,083
+6,945
| +1% | +$299K |
|
|
NTUS
1780
DELISTED
Natus Medical Inc
NTUS
| $18.6M | ﹤0.01% |
563,688
-5,297
| -0.9% | -$170K |
|
1781
Sprouts Farmers Market
SFM
$7.71B
| $18.6M | ﹤0.01% |
959,287
+26,324
| +3% | +$510K |
|
1782
TriMas Corp
TRS
$1.39B
| $18.5M | ﹤0.01% |
590,229
-86,077
| -13% | -$2.65M |
|
1783
Safety Insurance
SAFT
$1.52B
| $18.5M | ﹤0.01% |
200,262
-4,352
| -2% | -$424K |
|
|
ESPR
1784
DELISTED
Esperion Therapeutics
ESPR
| $18.5M | ﹤0.01% |
310,362
-7,680
| -2% | -$345K |
|
1785
Korea Electric Power
KEP
$14.8B
| $18.5M | ﹤0.01% |
1,561,551
+139,100
| +10% | +$1.6M |
|
|
AGR
1786
DELISTED
Avangrid, Inc.
AGR
| $18.5M | ﹤0.01% |
360,982
-6,620
| -2% | -$330K |
|
1787
LGI Homes
LGIH
$1.37B
| $18.5M | ﹤0.01% |
261,167
-12,570
| -5% | -$956K |
|
1788
Restaurant Brands International
QSR
$26.7B
| $18.4M | ﹤0.01% |
288,963
+3,534
| +1% | +$237K |
|
|
MIC
1789
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $18.3M | ﹤0.01% |
428,174
+20,072
| +5% | +$829K |
|
1790
Myers Industries
MYE
$1.25B
| $18.3M | ﹤0.01% |
1,098,893
-15,914
| -1% | -$265K |
|
|
NVTA
1791
DELISTED
Invitae Corporation
NVTA
| $18.3M | ﹤0.01% |
1,132,090
-7,648
| -0.7% | -$135K |
|
1792
Editas Medicine
EDIT
$432M
| $18.2M | ﹤0.01% |
615,485
+1,155
| +0.2% | +$28.8K |
|
1793
Heritage Financial
HFWA
$1.23B
| $18.2M | ﹤0.01% |
643,789
-7,480
| -1% | -$206K |
|
1794
BOK Financial
BOKF
$8.85B
| $18.2M | ﹤0.01% |
208,259
+2,835
| +1% | +$231K |
|
|
AIMT
1795
DELISTED
Aimmune Therapeutics
AIMT
| $18.2M | ﹤0.01% |
543,131
-13,649
| -2% | -$382K |
|
1796
Clearway Energy Class C
CWEN
$7.02B
| $18.2M | ﹤0.01% |
909,900
-49,445
| -5% | -$957K |
|
1797
Unitil
UTL
$992M
| $18.1M | ﹤0.01% |
293,505
-4,271
| -1% | -$264K |
|
|
SAGE
1798
DELISTED
Sage Therapeutics
SAGE
| $18.1M | ﹤0.01% |
251,127
-32,961
| -12% | -$4.05M |
|
|
THR
1799
DELISTED
Thermon Group Holdings
THR
| $18.1M | ﹤0.01% |
675,901
-37,858
| -5% | -$954K |
|
|
VRTU
1800
DELISTED
Virtusa Corporation
VRTU
| $18.1M | ﹤0.01% |
399,210
-10,946
| -3% | -$447K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.